X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (6) 6
humans (6) 6
index medicus (6) 6
male (6) 6
middle aged (6) 6
aged (5) 5
cancer (5) 5
liver cancer (4) 4
analysis (3) 3
liver cirrhosis - virology (3) 3
[ sdv.mhep.heg ] life sciences [q-bio]/human health and pathology/hépatology and gastroenterology (2) 2
abridged index medicus (2) 2
adult (2) 2
aged, 80 and over (2) 2
anrs co12 cirvir (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
antiviral agents - therapeutic use (2) 2
chemotherapy (2) 2
cohort studies (2) 2
drug therapy (2) 2
family medical history (2) 2
france (2) 2
gastroenterology & hepatology (2) 2
hematology, oncology and palliative medicine (2) 2
hepatitis (2) 2
hepatitis c, chronic - complications (2) 2
hepatoma (2) 2
kaplan-meier estimate (2) 2
liver (2) 2
liver cirrhosis - complications (2) 2
metastasis (2) 2
multivariate analysis (2) 2
oncology (2) 2
practice guidelines as topic (2) 2
prospective studies (2) 2
risk-factors (2) 2
tumors (2) 2
[ sdv.can ] life sciences [q-bio]/cancer (1) 1
[ sdv.spee ] life sciences [q-bio]/santé publique et épidémiologie (1) 1
[sdv.can]life sciences [q-bio]/cancer (1) 1
[sdv.mhep.heg]life sciences [q-bio]/human health and pathology/hépatology and gastroenterology (1) 1
[sdv.spee]life sciences [q-bio]/santé publique et épidémiologie (1) 1
age distribution (1) 1
alanine transaminase - blood (1) 1
albumin (1) 1
angina pectoris (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic agents, hormonal - adverse effects (1) 1
antineoplastic agents, hormonal - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antiviral treatment (1) 1
article (1) 1
aspartate aminotransferases - blood (1) 1
atherosclerosis (1) 1
bias (1) 1
bile duct neoplasms - drug therapy (1) 1
bile duct neoplasms - genetics (1) 1
bile ducts, intrahepatic (1) 1
bilirubin (1) 1
biopsy (1) 1
biopsy, needle (1) 1
blood platelets (1) 1
body mass index (1) 1
cancer therapies (1) 1
carcinoma - drug therapy (1) 1
carcinoma - genetics (1) 1
carcinoma, hepatocellular - diagnostic imaging (1) 1
carcinoma, hepatocellular - drug therapy (1) 1
carcinoma, hepatocellular - epidemiology (1) 1
carcinoma, hepatocellular - etiology (1) 1
carcinoma, hepatocellular - mortality (1) 1
carcinoma, hepatocellular - therapy (1) 1
carcinoma, hepatocellular - virology (1) 1
cardiac & cardiovascular systems (1) 1
cardiovascular disease (1) 1
cardiovascular diseases - epidemiology (1) 1
cardiovascular diseases - etiology (1) 1
cardiovascular diseases - therapy (1) 1
care and treatment (1) 1
cerebral infarction (1) 1
cetuximab (1) 1
cholangiocarcinoma - drug therapy (1) 1
cholangiocarcinoma - genetics (1) 1
cirrhosis (1) 1
cisplatin (1) 1
clinical trials (1) 1
clinical-trials (1) 1
cohort (1) 1
colorectal cancer (1) 1
colorectal neoplasms - drug therapy (1) 1
colorectal-cancer (1) 1
combination (1) 1
common bile duct neoplasms - drug therapy (1) 1
common bile duct neoplasms - genetics (1) 1
comparative analysis (1) 1
continuous-infusion (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 819 - 828
Summary Background Gemcitabine plus a platinum-based agent (eg, cisplatin or oxaliplatin) is the standard of care for advanced biliary cancers. We investigated... 
Hematology, Oncology and Palliative Medicine | GROWTH-FACTOR RECEPTOR | MULTICENTER | CISPLATIN | ONCOLOGY | COLORECTAL-CANCER | CLINICAL-TRIALS | GALLBLADDER | COMBINATION | TUMORS | CHEMOTHERAPY | GALL-BLADDER CANCER | ras Proteins - genetics | Peripheral Nervous System Diseases - chemically induced | Proto-Oncogene Proteins p21(ras) | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Alanine Transaminase - blood | Organoplatinum Compounds - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Oxaliplatin | Common Bile Duct Neoplasms - drug therapy | Adult | Bile Ducts, Intrahepatic | Female | Bile Duct Neoplasms - genetics | Cetuximab | Neutropenia - chemically induced | Common Bile Duct Neoplasms - genetics | Bile Duct Neoplasms - drug therapy | Carcinoma - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | Deoxycytidine - administration & dosage | Gallbladder Neoplasms - genetics | Proto-Oncogene Proteins - genetics | Disease-Free Survival | Gallbladder Neoplasms - drug therapy | Aspartate Aminotransferases - blood | Cholangiocarcinoma - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Intention to Treat Analysis | Cholangiocarcinoma - genetics | Carcinoma - genetics | Aged | Mutation | Deoxycytidine - analogs & derivatives | Chemotherapy | Product development | Gemcitabine | Comparative analysis | Cancer
Journal Article
Hepatology, ISSN 0270-9139, 10/2016, Volume 64, Issue 4, pp. 1136 - 1147
Journal Article
American Heart Journal, ISSN 0002-8703, 04/2018, Volume 198, pp. 4 - 17
The objective was to examine the role of a sustained virological response (SVR) on major adverse cardiovascular events (MACEs) in patients with compensated... 
ETHNIC-DIFFERENCES | HEART-DISEASE | CARDIAC & CARDIOVASCULAR SYSTEMS | VIRUS-INFECTION | RISK-FACTORS | MYOCARDIAL-INFARCTION | ANTIVIRAL TREATMENT | ANRS CO12 CIRVIR | EXTRAHEPATIC MANIFESTATIONS | PERIPHERAL ARTERIAL-DISEASE | MIXED CRYOGLOBULINEMIA | Immunohistochemistry | Predictive Value of Tests | Age Distribution | Prevalence | Prognosis | Humans | Middle Aged | Cardiovascular Diseases - therapy | Hepatitis C, Chronic - physiopathology | Male | Hepatitis C, Chronic - complications | Cardiovascular Diseases - epidemiology | Female | Retrospective Studies | France | Liver Function Tests | Severity of Illness Index | Cardiovascular Diseases - etiology | Risk Assessment | Antiviral Agents - therapeutic use | Liver Cirrhosis - complications | Kaplan-Meier Estimate | Proportional Hazards Models | Survival Rate | Hepatitis C, Chronic - drug therapy | Liver Cirrhosis - virology | Liver Cirrhosis - pathology | Sex Distribution | Aged | Biopsy, Needle | Cohort Studies | Control | Hepatitis C | Analysis | Myocardial infarction | Heart | Heart attacks | Viremia | Liver | Viruses | Cardiovascular disease | Infections | Bilirubin | Family medical history | Multivariate analysis | Hepatitis | Body mass index | Liver cancer | Ischemia | Blood platelets | Atherosclerosis | Heart diseases | Hypertension | Cerebral infarction | Stroke | Level (quantity) | Mortality | Diabetes mellitus | Albumin | Principal components analysis | Serum albumin | Angina pectoris | Patients | Coronary artery disease | Ethnic factors | Cirrhosis | Biopsy | Coronary vessels | Infarction | Diabetes | Hepatitis C virus | Smoking
Journal Article
Journal Article
Fundamental & Clinical Pharmacology, ISSN 0767-3981, 02/2013, Volume 27, Issue 1, pp. 113 - 119
Journal Article
Gastroenterology, ISSN 0016-5085, 08/2018, Volume 155, Issue 2, pp. 431 - 442.e10
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.